{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/PSUS/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T13:34:01.901Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":13005,"canonical_name":"Pershing Square USA, Ltd.","cik":"0002002660","uei":null,"lei":null,"duns":null,"ticker":"PSUS"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":10},"count":10,"timeline":[{"ts":"2026-08-28","kind":"sec.filing","form_type":"NPORT-P","title":"NPORT-P — Pershing Square USA, Ltd. — 2026-08-28","url_slug":"/sec/cik-0002002660/nport-p/0001410368-26-088161","accession_number":"0001410368-26-088161","importance":30},{"ts":"2026-08-25","kind":"sec.filing","form_type":"N-PX","title":"N-PX — Pershing Square USA, Ltd. — 2026-08-25","url_slug":"/sec/cik-0002002660/n-px/0001438934-26-001590","accession_number":"0001438934-26-001590","importance":30},{"ts":"2026-08-21","kind":"sec.filing","form_type":"N-CSRS","title":"N-CSRS — Pershing Square USA, Ltd. — 2026-08-21","url_slug":"/sec/cik-0002002660/n-csrs/0001193125-26-360100","accession_number":"0001193125-26-360100","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"4","title":"4 — Pershing Square USA, Ltd. — 2026-08-19","url_slug":"/sec/cik-0002002660/4/0000796848-26-000011","accession_number":"0000796848-26-000011","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Pershing Square USA, Ltd. — 2026-08-05","url_slug":"/sec/cik-0002002660/4/0000796848-26-000006","accession_number":"0000796848-26-000006","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Pershing Square USA, Ltd. — 2026-08-05","url_slug":"/sec/cik-0002002660/4/0000796848-26-000007","accession_number":"0000796848-26-000007","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"40-17G","title":"40-17G — Pershing Square USA, Ltd. — 2026-06-26","url_slug":"/sec/cik-0002002660/40-17g/0001193125-26-285680","accession_number":"0001193125-26-285680","importance":30},{"ts":"2026-06-17","kind":"sec.insider.p","reporter":"Herring Bruce","title":null,"shares":5000,"price_per_share":40.25,"usd_value":201250,"security_title":"Common Shares of Beneficial Interest","importance":50.20125},{"ts":"2026-06-17","kind":"sec.filing","form_type":"4","title":"4 — Pershing Square USA, Ltd. — 2026-06-17","url_slug":"/sec/cik-0002002660/4/0001193125-26-274438","accession_number":"0001193125-26-274438","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"497AD","title":"497AD — Pershing Square USA, Ltd. — 2026-06-15","url_slug":"/sec/cik-0002002660/497ad/0001193125-26-271147","accession_number":"0001193125-26-271147","importance":30}]}